Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 184.18 USD 0.86% Market Closed
Market Cap: 20.5B USD

During the last 3 months Quest Diagnostics Inc insiders have not bought any shares, and sold 9.1m USD worth of shares. The stock price has increased by 0% over this period (open performance analysis).

The last transaction was made on Nov 25, 2025 by Davis J. E. , who sold 1.8m USD worth of DGX shares.

Last Transactions:
Davis J. E.
$-1.8m
Gregg Vicky B
$-239.7k
Delaney Mark E
$-1.5m
Pfeiffer Gary M
$-270.3k
Prevoznik Michael E
$-15.5k
Prevoznik Michael E
$-32.7k
Prevoznik Michael E
$-5.3m
Plewman Patrick
$-365.4k
Plewman Patrick
$-829.4k
Plewman Patrick
$-355.5k
Plewman Patrick
$-623k
Kuppusamy Karthik
$-375.7k
Kuppusamy Karthik
$-509.7k
Delaney Mark E
$-153.2k
Delaney Mark E
$-153.6k
Davis J. E.
$-397.6k
Kuppusamy Karthik
$-434.4k
Prevoznik Michael E
$-789.3k
Doherty Catherine T.
$-935.1k
Doherty Catherine T.
$-125.9k
Prevoznik Michael E
$-104.1k
Doherty Catherine T.
$-142.2k
Prevoznik Michael E
$-91.1k
Prevoznik Michael E
$-103.3k
Doherty Catherine T.
$-153.7k
Plewman Patrick
$-54.3k
Doherty Catherine T.
$-90.8k
Delaney Mark E
$-66.2k
Gregg Vicky B
$-205.7k
Prevoznik Michael E
$-488.2k
Doherty Catherine T.
$-778.8k
Deppe Michael J
$-320.7k
View All Transactions

During the last 3 months Quest Diagnostics Inc insiders have not bought any shares, and sold 9.1m USD worth of shares. The stock price has increased by 0% over this period (open performance analysis).

The last transaction was made on Nov 25, 2025 by Davis J. E. , who sold 1.8m USD worth of DGX shares.

Sold
0-3
months
9.1m USD
5
3-6
months
3.1m USD
2
6-9
months
1.9m USD
4
9-12
months
2.1m USD
5
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Quest Diagnostics Inc
Insider Trading Chart

Quest Diagnostics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Quest Diagnostics Inc
Last Insider Transactions

Global
Insiders Monitor

Quest Diagnostics Inc
Glance View

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

DGX Intrinsic Value
190.48 USD
Undervaluation 3%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top